|
Eine Ebene nach oben |
Gruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 3
2021
Orth, Michael; Albrecht, Valerie; Seidl, Karin; Kinzel, Linda; Unger, Kristian; Hess, Julia; Kreutzer, Lisa; Sun, Na; Stegen, Benjamin; Nieto, Alexander; Maas, Jessica; Winssinger, Nicolas; Friedl, Anna A.; Walch, Axel K.; Belka, Claus; Zitzelsberger, Horst; Niyazi, Maximilian und Lauber, Kirsten
(17. März 2021):
Inhibition of HSP90 as a Strategy to Radiosensitize Glioblastoma: Targeting the DNA Damage Response and Beyond.
In: Frontiers in Oncology, Bd. 11, 612354
[PDF, 13MB]
2020
Ernst, Anne; Hennel, Roman; Krombach, Julia; Kapfhammer, Heidi; Brix, Nikko; Zuchtriegel, Gabriele; Uhl, Bernd; Reichel, Christoph A.; Frey, Benjamin; Gaipl, Udo S.; Winssinger, Nicolas; Shirasawa, Senji; Sasazuki, Takehiko; Sperandio, Markus; Belka, Claus und Lauber, Kirsten
(August 2020):
Priming of Anti-tumor Immune Mechanisms by Radiotherapy Is Augmented by Inhibition of Heat Shock Protein 90.
In: Frontiers in Oncology, Bd. 10, 1668: S. 1-16
[PDF, 14MB]
2016
Kinzel, Linda; Ernst, Anne; Orth, Michael; Albrecht, Valerie; Hennel, Roman; Brix, Nikko; Frey, Benjamin; Gaipl, Udo S.; Zuchtriegel, Gabriele; Reichel, Christoph A.; Blutke, Andreas; Schilling, Daniela; Multhoff, Gabriele; Li, Minglun; Niyazi, Maximilian; Friedl, Anna A.; Winssinger, Nicolas; Belka, Claus und Lauber, Kirsten
(2016):
A novel HSP90 inhibitor with reduced hepatotoxicity synergizes with radiotherapy to induce apoptosis, abrogate clonogenic survival, and improve tumor control in models of colorectal cancer.
In: Oncotarget, Bd. 7, Nr. 28: S. 43199-43219